ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.605,14
0,82%
S&P 500
5.509,01
0,00%
Dow Jones
39.308,00
0,00%
Euro vs US Dollar
1,08313
0,19%
Bitcoin
55.300,27
-2,95%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) News

INSM

Insmed (INSM)

Insmed Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INSM
DatumZeitQuelleÜberschriftSymbolFirma
05/07/202414h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
03/07/202415h03PR Newswire (US)Additional Positive Data from Pivotal ASPEN Study of Brensocatib in Patients with Bronchiectasis to be Presented at the 7th World Bronchiectasis ConferenceNASDAQ:INSMInsmed Inc
27/06/202414h00PR Newswire (US)Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025NASDAQ:INSMInsmed Inc
13/06/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
12/06/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
07/06/202414h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
05/06/202422h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
05/06/202414h00PR Newswire (US)Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
04/06/202413h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
03/06/202422h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
30/05/202423h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202423h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202423h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202423h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202423h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202423h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
30/05/202422h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
30/05/202422h05PR Newswire (US)Insmed to Host Commercial Webinar on June 4, 2024NASDAQ:INSMInsmed Inc
30/05/202422h02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INSMInsmed Inc
30/05/202414h00PR Newswire (US)Insmed Announces Pricing of $650 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
29/05/202400h21PR Newswire (US)Insmed Announces Proposed $500 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
28/05/202422h51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202422h49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202422h47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202422h46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202422h40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202422h14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202412h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
28/05/202412h30PR Newswire (US)Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
28/05/202412h30PR Newswire (US)Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Kürzlich von Ihnen besucht

NASDAQ
AMZN
Amazon.com
TG
DBK
Deutsche Bank
USOTC
DTEGY
Deutsche Telekom (QX)
TG
ALV
Allianz
USOTC
BNPQY
BNP Paribas (QX)
TG
DTE
Deutsche Telekom
TG
RHM
Rheinmetall
DBI
TDXP
Tec DAX
NASDAQ
AAPL
Apple
AMEX
XLE
Energy Select Sector SPDR
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
TG
NOV
Novo Nordisk
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten